MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
608.09%
Quick Ratio
527.78%
Cash Ratio
151.63%
Debt to Asset Ratio
10.86%
Unit: Dollar
Assets Breakdown
    • Fixed deposits placed with finan...
    • Investments in equity securities
    • Property, plant and equipment, n...
    • Others
Liabilities Breakdown
    • As at june 30, 2026, common stoc...
    • Accumulated deficit
    • Additional paid in capital
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and bank balances
1,232,658
1,337,554
2,383,369
1,153,121
Fixed deposits placed with financial institutions (including 1,129,587 and 1,553,322 of fixed deposits with original maturities more than three months as of june 30, 2026 and december 31, 2025 respectively)
2,288,874
2,627,408
1,656,336
1,741,532
Trade receivables, net of allowance for credit losses of 849,330 and 703,995 as of june 30, 2026 and december 31, 2025 respectively (including nil and 31,420 of trade receivables from related party as of june 30, 2026 and december 31, 2025 respectively)
15,544
79,860
505,885
1,522,158
Other receivables, deposits and prepayments
108,975
88,983
81,728
98,903
Other assets
583,331
333,332
83,333
-
Tax recoverable
61,135
61,611
61,384
103,640
Inventories
652,892
667,154
676,703
1,007,448
Total current assets
4,943,409
5,195,902
5,448,738
5,626,802
Operating lease right-of-use assets
146,542
163,113
177,737
186,082
Finance lease right-of-use assets
72,129
75,383
-
-
Property, plant and equipment, net
1,537,800
1,577,279
1,598,769
1,570,584
Investments in equity securities
2,026,543
2,028,453
2,027,540
237,760
Total non-current assets
3,783,014
3,844,228
3,804,046
1,994,426
Total assets
8,726,423
9,040,130
9,252,784
7,621,228
Trade payables
7,896
2,137
2,335
184,600
Other payables and accrued liabilities (including 233,332 and 83,333 of other payables from related party as of march 31, 2026 and december 31, 2025 respectively)
-
589,700
401,611
375,380
Other payables and accrued liabilities (including 296,331 and 83,333 of other payables from related party as of june 30, 2026 and december 31, 2025 respectively)
608,537
-
-
-
Operating lease liabilities
56,677
58,251
59,147
56,803
Finance lease liabilities
6,865
7,770
-
-
Advance payment from customer
8,351
8,416
8,385
11,264
Amount owing to directors
124,612
130,196
49,479
49,976
Total current liabilities
812,938
796,470
520,957
678,023
Operating lease liabilities
89,350
103,802
116,899
126,943
Deferred tax liabilities
-
-
-
0
Finance lease liabilities
45,693
46,605
-
-
Total non-current liabilities
135,043
150,407
116,899
126,943
Total liabilities
947,981
946,877
637,856
804,966
As at june 30, 2026, common stock, no par value 300,000,000 shares authorized and 2,417,314 shares outstanding, and preferred stock, no par value 30,000,000 shares authorized and no shares outstanding. as at december 31, 2025, common stock, no par value 300,000,000 shares authorized and 2,417,314 shares outstanding, and preferred stock, no par value 30,000,000 share authorized and no shares outstanding (on a post-reverse stock split basis)
20,174,795
20,174,795
20,174,795
17,331,810
Additional paid in capital
-5,011,891
-5,011,891
-5,011,891
-5,011,891
Accumulated deficit
-7,257,253
-6,970,802
-6,427,227
-5,391,110
Accumulated other comprehensive losses
-127,209
-98,849
-120,749
-112,547
Total stockholders' equity
7,778,442
8,093,253
8,614,928
6,816,262
Total liabilities and stockholders' equity
8,726,423
9,040,130
9,252,784
7,621,228
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Fixed deposits placedwith financial...$2,288,874 (1.97%↑ Y/Y)Cash and bankbalances$1,232,658 (51.40%↑ Y/Y)Inventories$652,892 (-46.29%↓ Y/Y)Other assets$583,331 Other receivables,deposits and prepayments$108,975 (-27.96%↓ Y/Y)Tax recoverable$61,135 (-39.75%↓ Y/Y)Trade receivables,net of allowance for...$15,544 (-99.16%↓ Y/Y)Investments in equitysecurities$2,026,543 (62.29%↑ Y/Y)Property, plant andequipment, net$1,537,800 (-3.46%↓ Y/Y)Operating leaseright-of-use assets$146,542 (-26.83%↓ Y/Y)Finance leaseright-of-use assets$72,129 Total current assets$4,943,409 (-22.51%↓ Y/Y)Total non-currentassets$3,783,014 (24.36%↑ Y/Y)Total assets$8,726,423 (-7.37%↓ Y/Y)Total liabilities andstockholders' equity$8,726,423 (-7.37%↓ Y/Y)Total stockholders'equity$7,778,442 (3.41%↑ Y/Y)Total liabilities$947,981 (-50.08%↓ Y/Y)Accumulated deficit-$7,257,253 (-55.00%↓ Y/Y)Additional paid in capital-$5,011,891 (0.00%↑ Y/Y)Accumulated othercomprehensive losses-$127,209 (-9.89%↓ Y/Y)As at june 30, 2026,common stock, no par...$20,174,795 (16.40%↑ Y/Y)Total currentliabilities$812,938 (-53.75%↓ Y/Y)Total non-currentliabilities$135,043 (-4.46%↓ Y/Y)Other payables andaccrued liabilities...$608,537 Amount owing todirectors$124,612 (689.23%↑ Y/Y)Operating leaseliabilities$56,677 (1.56%↑ Y/Y)Advance payment fromcustomer$8,351 (-26.41%↓ Y/Y)Trade payables$7,896 (-99.42%↓ Y/Y)Finance leaseliabilities$6,865 Operating leaseliabilities$89,350 (-36.79%↓ Y/Y)Finance leaseliabilities$45,693

BioNexus Gene Lab Corp (BGLC)

BioNexus Gene Lab Corp (BGLC)